• Gilead, Goldfinch Enter Kidney Collaboration contractpharma
    May 10, 2019
    Gilead Sciences and Goldfinch Bio have entered a collaboration to discover, develop and commercialize a pipeline of therapeutics for diabetic kidney disease (DKD) and certain orphan kidney diseases.
PharmaSources Customer Service